Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer

Name: Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
License: Public Domain

Gustave Roussy, Cancer Campus, Grand Paris

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

nsclc (advanced non-small cell lung cancer)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 343849
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.